Publication | Closed Access

Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies

Medicinal ChemistryAldo-keto ReductaseOxysterolBiochemistryMedicineAldose ReductaseDiabetesNatural SciencesNovel Spiroindoline DerivativesDiabetic ComplicationsDrug DevelopmentPharmacologyDrug DiscoveryOxidative Stress